KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership22,026 shares
Latest Disclosed Value $ 404,398
Jpmorgan Chase & Co reports 13.22% increase in ownership of 4XC1 / KalVista Pharmaceuticals, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 22,026 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $341,403 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 19,454 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of 13.22% during the quarter. The current value of the position is $506,818 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 22,026 2,572 13.22 404 28.66 0.0000
2026-02-11 2025-12-31 13F KALVISTA PHARMACEUTICALS IN COMMON 483497103 19,454 -1,305 -6.29 314 24.60 0.0000
2025-11-26 2025-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 20,759 -2,459 -10.59 253 -3.82 0.0000
2025-11-07 2025-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 20,759 -2,459 253 0.0000
2025-08-12 2025-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 23,218 -379,286 -94.23 262 -94.36 0.0000
2025-05-12 2025-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 402,504 381,244 1,793.25 4,645 2,480.00 0.0003
2025-02-12 2024-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 21,260 -1,350 -5.97 180 -31.03 0.0000
2024-12-26 2024-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 22,610 1,670 7.98 262 6.10 0.0000
2024-11-08 2024-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 22,610 1,670 262 0.0000
2024-12-26 2024-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 20,940 -69,620 -76.88 247 -77.09 0.0000
2024-08-12 2024-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 20,940 -69,620 247 0.0000
2024-12-26 2024-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 90,560 63,768 238.01 1,074 227.44 0.0001
2024-05-10 2024-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 90,560 63,768 1,074 0.0001
2024-12-26 2023-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 26,792 -244,149 -90.11 328 -87.43 0.0000
2024-02-12 2023-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 26,792 -244,149 328 0.0000
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 270,941 -19,334 -6.66 2,609 -0.11 0.0003
2023-08-11 2023-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 290,275 -44,034 -13.17 2,612 -0.57 0.0003
2023-05-18 2023-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 334,309 7,306 2.23 2,627 131,250.00 0.0003
2023-05-11 2023-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 315,558 -11,445 2,480 0.0000
2023-02-13 2022-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 327,003 190,809 140.10 2 -99.90 0.0003
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 136,194 -7,657 -5.32 1,976 39.55 0.0003
2022-08-11 2022-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 143,851 130,427 971.60 1,416 615.15 0.0002
2022-05-11 2022-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 13,424 2,677 24.91 198 39.44 0.0000
2022-02-11 2021-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 10,747 1,656 18.22 142 -10.69 0.0000
2022-02-10 2021-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 10,747 1,656 142 0.0000
2021-11-12 2021-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 9,091 332 3.79 159 -24.29 0.0000
2021-08-12 2021-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 8,759 425 5.10 210 -1.87 0.0000
2021-05-12 2021-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 8,334 -27,239 -76.57 214 -68.34 0.0000
2021-02-19 2020-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 35,573 12,293 52.80 676 129.93 0.0001
2021-02-11 2020-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 35,573 12,293 676 16.7180
2020-11-12 2020-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 23,280 -7,848 -25.21 294 -21.81 0.0000
2020-11-12 2020-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 23,280 294
2020-08-11 2020-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 31,128 -28,237 -47.57 376 -17.18 0.0001
2020-05-12 2020-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 59,365 40,223 210.13 454 33.14 0.0001
2020-02-11 2019-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 19,142 15,315 400.18 341 675.00 0.0001
2019-11-12 2019-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 3,827 -33,481 -89.74 44 -94.54 0.0000
2019-08-07 2019-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 37,308 -24,754 -39.89 806 -54.62 0.0002
2019-05-07 2019-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 62,062 25,267 68.67 1,776 144.29 0.0004
2019-02-11 2018-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 36,795 31,183 555.65 727 486.29 0.0002
2018-11-13 2018-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COMMON 483497103 5,612 -1,650 -22.72 124 110.17 0.0000
2018-11-07 2018-09-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 5,612 -1,650 124
2018-08-14 2018-06-30 13F KALVISTA PHARMACEUTICALS COMMON 483497103 7,262 -13,678 -65.32 59 -70.35 0.0000
2018-05-10 2018-03-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 20,940 -8,133 -27.97 199 -29.68 0.0000
2018-02-13 2017-12-31 13F KALVISTA PHARMACEUTICALS COMMON 483497103 29,073 29,073 283 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.